IdentificationGeneric Name(1s,3r,4r,6s)-1,3,4,6-TetrapkisphosphateDrugBank Accession NumberDB04300BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate (DB04300)× CloseWeightAverage: 500.0755 Monoisotopic: 499.928709756 Chemical FormulaC6H16O18P4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionNot AvailableAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as inositol phosphates. These are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety.KingdomOrganic compoundsSuper ClassOrganic oxygen compoundsClassOrganooxygen compoundsSub ClassAlcohols and polyolsDirect ParentInositol phosphatesAlternative ParentsMonoalkyl phosphates / Cyclohexanols / Organic oxides / Hydrocarbon derivativesSubstituentsAliphatic homomonocyclic compound / Alkyl phosphate / Cyclohexanol / Hydrocarbon derivative / Inositol phosphate / Monoalkyl phosphate / Organic oxide / Organic phosphoric acid derivative / Phosphoric acid ester / Secondary alcoholMolecular FrameworkAliphatic homomonocyclic compoundsExternal Descriptorsmyo-inositol tetrakisphosphate (CHEBI:16155) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyZAWIXNGTTZTBKV-JMVOWJSSSA-NInChIInChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)5(23-27(15,16)17)2(8)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2+,3-,4+,5-,6+IUPAC Name{[(1R,2s,3S,4S,5r,6R)-2,5-dihydroxy-3,4,6-tris(phosphonooxy)cyclohexyl]oxy}phosphonic acidSMILESO[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksHuman Metabolome DatabaseHMDB0001187KEGG CompoundC04477PubChem Compound121969PubChem Substance46506539ChemSpider17216082ChEBI16155ZINCZINC000071789370PDBe LigandI4PPDB Entries1z2oClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility11.5 mg/mLALOGPSlogP-0.45ALOGPSlogP-4.3ChemaxonlogS-1.6ALOGPSpKa (Strongest Acidic)0.35ChemaxonPhysiological Charge-8ChemaxonHydrogen Acceptor Count14ChemaxonHydrogen Donor Count10ChemaxonPolar Surface Area307.5 Å2ChemaxonRotatable Bond Count8ChemaxonRefractivity79.27 m3·mol-1ChemaxonPolarizability33.68 Å3ChemaxonNumber of Rings1ChemaxonBioavailability0ChemaxonRule of FiveNoChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.5918Blood Brain Barrier+0.9414Caco-2 permeable-0.6991P-glycoprotein substrateNon-substrate0.7889P-glycoprotein inhibitor INon-inhibitor0.8014P-glycoprotein inhibitor IINon-inhibitor0.9703Renal organic cation transporterNon-inhibitor0.9224CYP450 2C9 substrateNon-substrate0.823CYP450 2D6 substrateNon-substrate0.8507CYP450 3A4 substrateNon-substrate0.6466CYP450 1A2 substrateNon-inhibitor0.94CYP450 2C9 inhibitorNon-inhibitor0.92CYP450 2D6 inhibitorNon-inhibitor0.9294CYP450 2C19 inhibitorNon-inhibitor0.8948CYP450 3A4 inhibitorNon-inhibitor0.9813CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9738Ames testNon AMES toxic0.8837CarcinogenicityNon-carcinogens0.6979BiodegradationNot ready biodegradable0.8459Rat acute toxicity2.2264 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9125hERG inhibition (predictor II)Non-inhibitor0.9425  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 